Correction Pharmaceutical Manufacturers By the end of June 2018, the group has 142 subsidiaries under its jurisdiction, with more than 100,000 employees and stock assets of 17 billion yuan. It has 24 dosage forms and more than 2,000 varieties of medicine and health products, including 109 exclusive varieties.
The production companies include
Tongyi Pharmaceutical Group Co.
Corrections Pharmaceutical Group Xuchang Corrections Pharmaceutical Co.
Shanghai Corrections Shentian Pharmaceutical Co.
Jiaozuo Corrections Union Sanitary Material Co.
Liuhe Zhengtong Pharmaceutical Co.
Fujian Yongchun Pharmaceutical Ltd.
Liaoning Revision Bio-Pharmaceutical Co.
Shenyang Revision Pharmaceutical Co.
Revision Pharmaceutical Group Sichuan Pharmaceutical Co.
Fusong County Traditional Chinese Medicine Co. Extended information:
Development history
The first stage
May 1995, the founding of the Tonghua Pharmaceutical Industry Research Institute of Pharmaceuticals, Fixed Assets 200,000 yuan, liabilities of 4 million yuan.
May 2000, changed its name to Jilin Amendment Pharmaceutical Group Co.
January 2001, the first company in Jilin Province to pass the GMP certification.
February 2001, the Ministry of Science and Technology of the People's Republic of China recognized Revised Pharmaceuticals as a "National Torch Plan Key High-tech Enterprise".
In June 2001, Shouxiang Pharmaceutical Group Co., Ltd. was recognized by the Jilin Provincial Bureau of Quality and Technical Supervision as an "Advanced Enterprise of Quality Management in Jilin Province".
In August 2001, the trademark of "Shou Shu" was recognized as a famous trademark of Jilin Province.
In November, 2001, Jilin Revision Pharmaceutical Group Co., Ltd. was named "Top 100 Private Enterprises in Jilin Province" by the Provincial Administration for Industry and Commerce and the Provincial Association of Individual Workers and Private Enterprises.
In January, 2003, the State Administration for Industry and Commerce honored Shouzhu Pharmaceutical Group as a "National Enterprise of Honoring Contracts and Keeping Credit".
In December 2003, the Ministry of Science and Technology of the People's Republic of China recognized Shoujou Pharmaceutical Group as the "National High-Tech Research and Development Program Achievement Industrialization Base".
In March 2004, China Quality Supervision and Administration Association and China Quality Standard Research Center recognized Jilin Shouzhu Pharmaceutical Group as "2004 (the first) China's well-known brands in the Chinese market quality - reputation - service satisfaction unit of the top ten well-known brands of China's pharmaceutical industry".
April 2004, the construction of the largest and most modernized biomedical science and technology park in China, with a total investment of 1 billion yuan.
August 2004, the acquisition of Jilin Province, Shuangyang Plum Deer Group, carrying 340 million yuan of special national debt project.
The second stage
November 2004, changed its name to Amendment Pharmaceutical Group.
In September 2005, the raw material synthesis and preparation production line of "Gatifloxacin", the first class new drug of China, was completed with an investment of 120 million yuan.
November 2005, the establishment ceremony of Sichuan Shou Shu Pharmaceutical Co.
In May 2007, Shouxiang Pharmaceutical Group Co., Ltd. was honored as a unit of "Honoring Contracts and Keeping Credit" for 8 consecutive years.
July 2007, Shouxiang Pharmaceutical Group invested 1 billion dollars to build "Shouxiang Biomedical Industrial Park" in Changchun Hi-Tech Development Zone.
August 2007, Shouxiang Pharmaceutical Group and the School of Life Sciences of Jilin University jointly established an open laboratory for biopharmaceuticals.
In March 2009, the Beijing Revision Pharmaceutical Science and Technology Industrial Base of the Revision Pharmaceutical Group was officially opened
In September 2009, Revision Pharmaceutical's Revision Milk Powder "Xiu Xiu Ai" was put into operation, and has already been distributed in Shandong and Hebei.
Baidu Encyclopedia-Correction Pharmaceutical Group
Correction Pharmaceuticals-Group Profile